Puma Biotechnology Inc
Giá mua
Cập nhật

PBYI a speculative biotech LONG

142
PBYI according to the recent earnings as no earnings nor revenue. This is typical in the biotechnology sector.

This 4H chart shows a consistent downtrend with a couple of minor pullback corrections shown with a Doji followed

by a green engulfing candle but with low volume and the K/D lines of the MACD did not on the histogram.

In the present, the volume pattern shows relatively high selling volume then reversed to buying volume which is above the

moving 50 period average shown as the green horizontal line. Moreover, in this episode, the MACD/Signal lines have crossed

and curled up. The histogram has sent positive after being negative since early February.

I interpret this as being an early reversal now ripe for entry. Just like in nature, the early bird gets the worm.

Buyer beware biotechnology stocks that have market cap based on high potentials are speculative but potentially

offer high rewards. I see a reasonable target as a 50% retracement of the downturn or about $ 3.50 ( this is

less than the upside of some analysts ) PGYI is up 10% today. the train is leaving the station with momentum.

I see a potential takeover or a low float short squeeze.

(See also the link below )
Giao dịch đang hoạt động
PGYI is up 9% but on less than average volume - could this be a fakeout or the reversal underway?
Giao dịch đang hoạt động
Price is up 30% over 3 days so no pump and dump but will close out a third of the calls and run the rest.

Thông báo miễn trừ trách nhiệm

Thông tin và các ấn phẩm này không nhằm mục đích, và không cấu thành, lời khuyên hoặc khuyến nghị về tài chính, đầu tư, giao dịch hay các loại khác do TradingView cung cấp hoặc xác nhận. Đọc thêm tại Điều khoản Sử dụng.